Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
1.10
Jul 15 • 03:59PM ET Dollar change+0.49 Percentage change(78.92%)
Aftermarket Close
1.19
Aftermarket • 06:53PM ET Dollar change+0.09 Percentage change(8.18%)
Today, 12:15 PMChina Pharma says it knows of no undisclosed material information after NYSE American inquiry into unusual trading
Index
-
Market Cap
44.57M
Enterprise Value
47.96M
Income
-3.55M
Sales
3.99M
Book/sh
0.92
Cash/sh
0.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
221
IPO
Apr 17, 2002
P/E
-
Forward P/E
-
PEG
-
P/S
11.17
P/B
1.20
P/C
262.17
P/FCF
297.13
EV/EBITDA
-
EV/Sales
12.02
Quick Ratio
0.07
Current Ratio
0.28
Debt/Eq
0.10
LT Debt/Eq
0.00
Option/Short
No / No
EPS (ttm)
-0.55
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
73.01% 53.14%
Sales past 3/5Y
-20.03% -17.53%
EPS Y/Y TTM
75.39%
Sales Y/Y TTM
-7.07%
EPS Q/Q
81.48%
Sales Q/Q
-13.44%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
6.62%
Insider Trans
0.00%
Inst Own
0.06%
Inst Trans
-7.95%
ROA
-11.87%
ROE
-15.99%
ROIC
-9.51%
Gross Margin
-30.80%
Oper. Margin
-90.13%
Profit Margin
-88.82%
SMA20
57.63%
SMA50
50.41%
SMA200
3.08%
Trades
Shs Outstand
40.52M
Shs Float
37.84M
52W High
2.03 -45.81%
52W Low
0.38 188.11%
Volatility
30.70% 17.08%
ATR (14)
0.19
RSI (14)
71.50
Beta
1.13
Rel Volume
92.17
Avg Volume
876.41K
Volume
80,775,251
Perf Week
61.72%
Perf Month
53.93%
Perf Quarter
78.14%
Perf Half Y
-15.38%
Perf YTD
-9.09%
Perf Year
-35.29%
Perf 3Y
-93.84%
Perf 5Y
-99.69%
Perf 10Y
-99.15%
Recom
-
Target Price
-
Prev Close
0.61
Price
1.10
Change
78.92%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
Today 12:12PM
May-14-26 08:56AM
Apr-04-25 04:05PM
Dec-18-24 08:30AM
Dec-13-24 08:00AM
08:00AM Loading…
Aug-19-24 08:00AM
Feb-23-24 04:05PM
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
10:05PM Loading…
Oct-01-22 10:05PM
Jul-18-22 08:00AM
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
10:10AM Loading…
Aug-11-20 10:10AM
Jun-04-20 07:59PM
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
07:10AM
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
06:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
06:00AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.
PresidentMs. Zhilin Li
BOD Secretary & IR ManagerMs. Huang Na C.F.A.